Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia

Indian Journal of Medical Research

Volumn 129, Issue 3, 2009, Pages 293-298

  Hassanzadeh, Taghi ^a,b   Firoozrai, Mohsen ^b   Zonouz, Abdolvahhab Ehsani ^b   Zavarehee, Abbas ^c   Paoli, Max ^d  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cholesteryl ester transfer protein; Iranian population; Primary combine hyperlipidaemia; Taq 1B polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAQ POLYMERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CETP PROTEIN, HUMAN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; FAMILIAL HYPERLIPEMIA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IRAN; MIDDLE AGED; RISK FACTOR;

ADULT; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; IRAN; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 67649643640     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yamashita S, Hirano K, Sakai N, Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta 2000; 1529: 257-75.
2. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated remnant- like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 2004; 109: 1918-25.
3. Schaefer EJ. Lipoproteins, nutrition and heart disease. Am J Clin Nutr 2002; 75: 191-212.
4. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990; 29: 1372-6.
5. Tall AR. Plasma lipid transfer proteins. Annu Rev Biochem 1995; 64: 235-57.
6. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res 2004; 45: 1967-74.
7. Klerkx AH, Tanck MW, Kastelein JJ, Molhuizen HO, Jukema JW, Zwinderman AH, et al. Haplotype analysis of the CETP gene: not Taq1B, but the closely linked -629C → A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Genet 2003; 12: 111-23.
8. Kuivenhoven JA, de Knijff P, Boer JM, Smalheer HA, Botma GJ, Seidell JC, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997; 17: 560-8.
9. Lottenberg AM, Nunes VS, Nakandakare ER, Neves M, Bernik M, Lagrost L, et al. The human cholesteryl ester transfer protein I405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters. J Nutr 2003; 133: 1800-5.
10. Kakko S, Tamminen M, Kesaniemi YA, Savolainen MJ. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. Atherosclerosis 1998; 136: 233-40.
11. Thompson JF, Lira ME, Durham LK, Clark RW, Bamberger MJ, Milos PM. Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis 2003; 167: 195-204.
12. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein - Taq IB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framinghon study. Arterioscler Thromb Vasc Biol 2000; 20: 1323-9.
13. Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, et al. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/ A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and - 629C/A polymorphisms. Atherosclerosis 2002; 161: 269-79.
14. Wu JH, Lee YT, Hsu HC, Hsieh LL. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis 2001; 159: 451-8.
15. Lu H, Inazu A, Moriyama Y, Higashikata T, Kawashiri MA, Yu W, et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J Mol Med 2003; 81: 246-55.
16. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, et al. Alcohol intake modulates the effect of a polymorphism of the choresteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low- density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
19. Girard-Globa A. A polymorphism of the gene coding for cholesterol ester transfer protein (CETP) that affects transfer of plasma cholesterol ester and its sensitivity to regulation. Biomed Pharmacother 1997; 51: 404-5.
20. Aouizerat BE, Allayee H, Cantor RM, Dallinga-Thie GM, Lanning CD, de Bruin TW, et al. Linkage of a candidate gene locus to familial combined hyperlipidemia. Lecithin: cholesterol acyltransferase on 16q. Arterioscler Thromb Vasc Biol 1999; 19: 2730-6.
21. Durlach A, Clavel C, Girard-Globa A, Durlach V. Sex dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 1999; 84: 3656-9.
22. Arashiro R, Katsuren K, Maung KK, Fukuyama S, Ohta T. Effect of a common mutation (D442G) of the cholesteryl ester transfer protein gene on lipids and lipoproteins in children. Pediatr Res 2001; 50: 455-9.
23. Tato F, Vega GL, Grundy SM. Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol 1995; 15: 446-51.
24. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high-density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 2000; 20: 507-15.
25. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998; 338: 86-93.
26. Schaefer EJ, Levy RI, Anderson DW, Danner RN, Brewer HB Jr. Plasma- triglycerides in regulation of H.D.L. cholesterol levels. Lancet 1978; 2: 391-3.
27. Davis CE, Gordon D, LaRosa J, Wood PD, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. Circulation 1980; 62: 24-30.
28. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.
29. Kastelein JJ. Refocusing on use of cholesteryl ester transfer protein inhibitors. Am J Cardiol 2007; 100: 47-52.
30. Schaefer EJ, Asztalos BF. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am J Cardiol 2007; 100: 25-31.
31. El Harchaoui K, van der Steeg WA, Stroes ES, Kastelein JJ. The role of CETP inhibition in dyslipidemia. Curr Atheroscler Rep 2007; 9: 125-33.
32. Cucuianu M, Coca M, Hâncu N. Reverse cholesterol transport and atherosclerosis. A mini review. Rom J Intern Med 2007; 45: 17-27.
33. Sviridov D, Nestel PJ. Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol 2007; 18: 157-63.
34. Boekholdt SM, Souverein OW, Tanck MW, Hovingh GK, Kuivenhoven JA, Peters RI, et al. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet 2006; 69: 263-70.